Literature DB >> 23168287

Indexes of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study).

Joseph L Blackshear1, Ewa M Wysokinska, Robert E Safford, Colleen S Thomas, Mark E Stark, Brian P Shapiro, Steven Ung, Gretchen S Johns, Dong Chen.   

Abstract

We correlated von Willebrand factor (VWF) activity indexes and brain natriuretic peptide (BNP) with measures of aortic stenosis (AS) severity, bleeding, symptoms, and freedom from death or aortic valve replacement. Patients with AS (n = 66 [16 mild, 20 moderate, and 30 severe]) and aortic valve replacement (n = 21) were assessed with VWF antigen, VWF latex agglutination immunoturbidic activity, platelet function analyzer collagen plus adenosine diphosphate (PFA-CADP), VWF multimer ratio, and BNP level after echocardiography. In patients with AS, the mean gradient correlated with BNP (Spearman r = 0.29, p = 0.02), VWF latex agglutination immunoturbidic activity/VWF antigen ratio (r = -0.41, p <0.001), PFA-CADP (r = 0.49, p <0.001), and VWF multimer ratio (r = -0.76, p <0.001). The area under the curve for detection of severe AS was 0.62 (95% confidence interval [CI] 0.48 to 0.77) by elevated BNP, 0.81 (95% CI 0.69 to 0.92) by PFA-CADP closure time, 0.69 (95% CI 0.55 to 0.82) by VWF latex agglutination immunoturbidic activity/VWF antigen ratio, and 0.86 (95% CI 0.76 to 0.95) by VWF multimer ratio. For the VWF multimer ratio, a threshold of 0.15 yielded a sensitivity and specificity for severe AS of 77% and positive predictive value of 74%. Bleeding (in 14%) was associated with a prolonged PFA-CADP time and reduced VWF latex agglutination immunoturbidic activity/VWF antigen ratio. Symptoms were associated with elevated BNP and low Duke Activity Status Index score. In 66 patients with AS, freedom from death (n = 4) or aortic valve replacement (n = 22) was associated with PFA-CADP (p = 0.003), VWF high-molecular-weight multimers (p = 0.009), and VWF latex agglutination immunoturbidic activity/VWF antigen ratio (p <0.001) but not BNP (p = 0.32). In severe AS versus aortic valve replacement, the PFA-CADP and VWF multimer ratio differed (p <0.001), but BNP and the VWF latex agglutination immunoturbidic activity/VWF antigen ratio did not. In conclusion, the VWF activity indexes were associated with AS severity and bleeding and were predictive of cardiovascular outcomes.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23168287      PMCID: PMC3932487          DOI: 10.1016/j.amjcard.2012.10.015

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  30 in total

1.  "Overestimation" of catheter gradients by Doppler ultrasound in patients with aortic stenosis: a predictable manifestation of pressure recovery.

Authors:  H Baumgartner; T Stefenelli; J Niederberger; H Schima; G Maurer
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

2.  Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery.

Authors:  C Solomon; U Budde; S Schneppenheim; E Czaja; C Hagl; H Schoechl; M von Depka; N Rahe-Meyer
Journal:  Br J Anaesth       Date:  2011-01-28       Impact factor: 9.166

3.  Functional von Willebrand Factor assays are not predictive for the absence of highest-molecular weight von Willebrand Factor multimers in patients with aortic-valve stenosis.

Authors:  Christoph Sucker; Peter Feindt; Rainer B Zotz; Marcus Stockschlaeder; Rüdiger E Scharf
Journal:  Thromb Haemost       Date:  2005-08       Impact factor: 5.249

4.  A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index).

Authors:  M A Hlatky; R E Boineau; M B Higginbotham; K L Lee; D B Mark; R M Califf; F R Cobb; D B Pryor
Journal:  Am J Cardiol       Date:  1989-09-15       Impact factor: 2.778

5.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

Authors:  E R DeLong; D M DeLong; D L Clarke-Pearson
Journal:  Biometrics       Date:  1988-09       Impact factor: 2.571

Review 6.  ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.

Authors:  Robert O Bonow; Blase A Carabello; Chatterjee Kanu; Antonio C de Leon; David P Faxon; Michael D Freed; William H Gaasch; Bruce Whitney Lytle; Rick A Nishimura; Patrick T O'Gara; Robert A O'Rourke; Catherine M Otto; Pravin M Shah; Jack S Shanewise; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2006-08-01       Impact factor: 29.690

7.  Acquired and reversible von Willebrand disease with high shear stress aortic valve stenosis.

Authors:  Kazunori Yoshida; Satoshi Tobe; Masahito Kawata; Masahiro Yamaguchi
Journal:  Ann Thorac Surg       Date:  2006-02       Impact factor: 4.330

8.  Acquired von Willebrand syndrome in aortic stenosis.

Authors:  André Vincentelli; Sophie Susen; Thierry Le Tourneau; Isabelle Six; Olivier Fabre; Francis Juthier; Anne Bauters; Christophe Decoene; Jenny Goudemand; Alain Prat; Brigitte Jude
Journal:  N Engl J Med       Date:  2003-07-24       Impact factor: 91.245

9.  Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival.

Authors:  Zeineb Hachicha; Jean G Dumesnil; Peter Bogaty; Philippe Pibarot
Journal:  Circulation       Date:  2007-05-28       Impact factor: 29.690

10.  von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).

Authors:  W L Nichols; M B Hultin; A H James; M J Manco-Johnson; R R Montgomery; T L Ortel; M E Rick; J E Sadler; M Weinstein; B P Yawn
Journal:  Haemophilia       Date:  2008-03       Impact factor: 4.287

View more
  10 in total

1.  Von Willebrand factor multimers during transcatheter aortic valve replacement-an additional clue for detecting post-procedural aortic regurgitation?

Authors:  Andras Peter Durko; Arie Pieter Kappetein
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

Review 2.  Structure-function and regulation of ADAMTS-13 protease.

Authors:  X L Zheng
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

Review 3.  Gastrointestinal Bleeding in Native and Prosthetic Valve Disease.

Authors:  Joseph L Blackshear
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-02-03

Review 4.  Von Willebrand disease in the elderly: clinical perspectives.

Authors:  John Chapin
Journal:  Clin Interv Aging       Date:  2018-08-31       Impact factor: 4.458

5.  Recurrent gastrointestinal bleeding in a patient with Heyde syndrome with elevated factor VIII levels: A case report.

Authors:  Omar Al-Radaideh; Iyad Farouji; Hossam Abed; Hamid Shaaban
Journal:  Int J Crit Illn Inj Sci       Date:  2021-12-18

6.  Pathologic Shear and Elongation Rates Do Not Cause Cleavage of Von Willebrand Factor by ADAMTS13 in a Purified System.

Authors:  Maria Bortot; Alireza Sharifi; Katrina Ashworth; Faye Walker; Allaura Cox; Katherine Ruegg; Nathan Clendenen; Keith B Neeves; David Bark; Jorge Di Paola
Journal:  Cell Mol Bioeng       Date:  2020-07-17       Impact factor: 2.321

7.  Platelet expression of stromal cell-derived factor-1 is associated with the degree of valvular aortic stenosis.

Authors:  Thomas Wurster; Roland Tegtmeyer; Oliver Borst; Dominik Rath; Tobias Geisler; Meinrad Gawaz; Boris Bigalke
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

8.  Platelet-to-Lymphocyte Ratio May Predict the Severity of Calcific Aortic Stenosis.

Authors:  Serkan Akdag; Aytac Akyol; Muntecep Asker; Ramazan Duz; Hasan Ali Gumrukcuoglu
Journal:  Med Sci Monit       Date:  2015-11-06

9.  Assessment of exercise-induced changes in von Willebrand factor as a marker of severity of aortic stenosis.

Authors:  Jo M Zelis; Frederik M Zimmermann; Froukje P J Andriessen; Patrick Houthuizen; Jop Van de Ven; Jolanda Leuverman; Nils P Johnson; Nico H J Pijls; Volkher Scharnhorst; Marcel Van 't Veer; Pim A L Tonino
Journal:  Open Heart       Date:  2020-03-04

10.  Von Willebrand factor multimer quantitation for assessment of cardiac lesion severity and bleeding risk.

Authors:  Christopher O Austin; Dong Chen; Colleen S Thomas; Robert E Safford; Brian P Shapiro; Justin A Bryan; Jordan C Ray; Joseph L Blackshear
Journal:  Res Pract Thromb Haemost       Date:  2017-12-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.